Quintiles was named to the CSO40, which is for security professionals in a broad range of disciplines.
We usually don't post press releases on our site about awards, however, this one for Quintiles looks at cloud computing and security, so we thought it a bit different. Quintiles was named to the CSO40—CSO is a content site for security professions ls in a broad range of disciplines. Specifically they focus on information security, physical security, business continuity, identity and access management, loss prevention and more. The Award recognizes 40 organizations for security projects and initiatives that demonstration outstanding business value and thought leadership. Quintiles' Trusted Cloud Services Model was recognized.
The security issues for cloud computing are a debate in our industry. But Quintiles has addressed these concerns ensuring cloud service providers are subject to the same level of security assurance as internal systems.Quintiles' approach builds upon its global security framework and application security assessment program, extending security controls directly into cloud service providers’ environments.
Read the full release here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
WCG Randomized 1,600 Participants for RSV Vaccine Trial
October 31st 2024A top 5 sponsor turned to WCG to recruit expecting mothers for its Phase III RSV vaccine trial. WCG support covered multiple countries and contributed almost one third of overall randomizations in the supported countries, bringing the study in ahead of schedule despite delays due to COVID-19 impacts on RSV seasonality. The sponsor met study timeline past enrollment by continuing to work with WCG’s retention support.